• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Res Pharmacol Drug Discov . Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL pro and M pro/ 3CL pro: molecular docking and simulatio

tetano

Editor, Senior Moderator
Curr Res Pharmacol Drug Discov


. 2021;2:100038.
doi: 10.1016/j.crphar.2021.100038. Epub 2021 Jun 5.
Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL [SUP]pro[/SUP] and M [SUP]pro[/SUP]/ 3CL [SUP]pro[/SUP]: molecular docking and simulation studies of three pertinent medicinal plant natural components


Devvret Verma[SUP] 1 [/SUP], Debasis Mitra[SUP] 2 [/SUP], Manish Paul[SUP] 3 [/SUP], Priya Chaudhary[SUP] 4 [/SUP], Anshul Kamboj[SUP] 1 [/SUP], Hrudayanath Thatoi[SUP] 3 [/SUP], Pracheta Janmeda[SUP] 4 [/SUP], Divya Jain[SUP] 4 [/SUP], Periyasamy Panneerselvam[SUP] 5 [/SUP], Rakesh Shrivastav[SUP] 6 [/SUP], Kumud Pant[SUP] 1 [/SUP], Pradeep K Das Mohapatra[SUP] 2 7 [/SUP]



Affiliations

Abstract

The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - coronavirus disease 2019 (COVID-19) has raised a severe global public health issue and creates a pandemic situation. The present work aims to study the molecular -docking and dynamic of three pertinent medicinal plants i.e. Eurycoma harmandiana, Sophora flavescens and Andrographis paniculata phyto-compounds against SARS-COV-2 papain-like protease (PL[SUP]pro[/SUP]) and main protease (M[SUP]pro[/SUP])/3-chymotrypsin-like protease (3CL[SUP]pro[/SUP]). The interaction of protein targets and ligands was performed through AutoDock-Vina visualized using PyMOL and BIOVIA-Discovery Studio 2020. Molecular docking with canthin-6-one 9-O-beta-glucopyranoside showed highest binding affinity and less binding energy with both PL[SUP]pro[/SUP] and M[SUP]pro[/SUP]/3CL[SUP]pro[/SUP] proteases and was subjected to molecular dynamic (MD) simulations for a period of 100ns. Stability of the protein-ligand complexes was evaluated by different analyses. The binding free energy calculated using MM-PBSA and the results showed that the molecule must have stable interactions with the protein binding site. ADMET analysis of the compounds suggested that it is having drug-like properties like high gastrointestinal (GI) absorption, no blood-brain barrier permeability and high lipophilicity. The outcome revealed that canthin-6-one 9-O-beta-glucopyranoside can be used as a potential natural drug against COVID-19 protease.

Keywords: Canthin-6-one 9-O-Beta-glucopyranoside; Molecular dynamics; Natural inhibitor; PLpro-Mpro/3CLpro; SARS-CoV-2 (COVID-19).
 
Back
Top Bottom